Cargando…
In vivo deglycosylation of recombinant glycoproteins in tobacco BY‐2 cells
Production of recombinant pharmaceutical glycoproteins has been carried out in multiple expression systems. However, N‐glycosylation, which increases heterogeneity and raises safety concerns due to the presence of non‐human residues, is usually not controlled. The presence and composition of N‐glyca...
Autores principales: | Herman, Xavier, Far, Johann, Peeters, Marie, Quinton, Loïc, Chaumont, François, Navarre, Catherine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10440984/ https://www.ncbi.nlm.nih.gov/pubmed/37266972 http://dx.doi.org/10.1111/pbi.14074 |
Ejemplares similares
-
Inactivation of N-Acetylglucosaminyltransferase I and α1,3-Fucosyltransferase Genes in Nicotiana tabacum BY-2 Cells Results in Glycoproteins With Highly Homogeneous, High-Mannose N-Glycans
por: Herman, Xavier, et al.
Publicado: (2021) -
Issue when expressing a recombinant protein under the control of p35S in Nicotiana tabacum BY-2 cells
por: Navarre, Catherine, et al.
Publicado: (2023) -
The N-glycan Glycoprotein Deglycosylation Complex (Gpd) from Capnocytophaga canimorsus Deglycosylates Human IgG
por: Renzi, Francesco, et al.
Publicado: (2011) -
Correction: The N-glycan Glycoprotein Deglycosylation Complex (Gpd) from Capnocytophaga canimorsus Deglycosylates Human IgG
por: Renzi, Francesco, et al.
Publicado: (2015) -
Inactivation of the β(1,2)-xylosyltransferase and the α(1,3)-fucosyltransferase genes in Nicotiana tabacum BY-2 Cells by a Multiplex CRISPR/Cas9 Strategy Results in Glycoproteins without Plant-Specific Glycans
por: Mercx, Sébastien, et al.
Publicado: (2017)